Navigation Links
Size does matter: Researchers adapt drug dosing to body size
Date:3/10/2008

University of Queensland researchers are leading the charge in adapting drug dosing to a society that is changing shape.

As the level of obesity in the Western World continues to rise dramatically, UQ School of Pharmacy's Dr Bruce Green says researchers face the ongoing challenge of determining just how dosages should be adjusted for different body sizes and compositions.

In a pharmacological sense, obesity presents a challenging role for clinicians, as the effects of altered body composition on the time course of drug response are poorly understood, Dr Green said.

[This] lack of dosing information [is of additional concern when you] consider that many of these individuals require therapeutic intervention for a variety of disease states.

It is this shortfall that the School of Pharmacy's Modelling and Simulation Group is looking to redress, as they work to optimise dosages for a variety of drugs in the overweight population.

The purpose of this study is linked to our overall strategy of ensuring that patients who are overweight do not get overdosed by dosing on total body weight, or underdosed by giving fixed doses to all patients, Dr Green said.

We propose that drugs should be dosed on our formula for lean body weight to match drug exposure across individuals of differing body compositions.

The results should minimise adverse events and improve efficacy of drugs, which we have already shown in an individualised dosing trial for enoxaparin (a blood thinning drug).


'/>"/>

Contact: Dr. Bruce Green
greenb@pharmacy.uq.edu.au
61-733-653-179
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Burroughs Wellcome Fund grants $9.75 million towards translational researchers
2. Researchers Design Promising Cancer Drug
3. Case Western Reserve University researchers identify colorectal cancer gene
4. On a roll: MIT researchers devise new cell-sorting system
5. Einstein researchers genetically engineer immune cells into potent weapons for battling HIV
6. Researchers control growth rate of replacement blood vessels, tissues
7. New protein discovery helps researchers understand autoimmune diseases
8. UF researchers warn parents about dangers of childhood foot burns
9. UCLA researchers find blood stem cells originate and are nurtured in the placenta
10. UCSF researchers validate new model for breast cancer risk assessment in multiple ethnic groups
11. Einstein researchers discover gene mutations linked to longer lifespans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
Breaking Medicine Technology: